ArticleBMC ophthalmology2020
Phacoemulsification in patients with uveitis: long-term outcomes.
Article in BMC ophthalmology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed.
- Hydrophobic and Hydrophilic IOLs in Patients with Uveitis - A Randomised Clinical Trial.Clinical ophthalmology (Auckland, N.Z.) · 2025Trial
- Ocular immune homeostasis-mechanisms of precise regulation through coordination of the eye, visual system and beyond: a narrative review.Annals of eye science · 2026Article
- Pars planitis: a study of clinical features and treatment results.BMC ophthalmology · 2026Article
- Investigating Non-Ocular Factors Affecting Postoperative Recovery Following Uveitic Cataract Surgery.Clinical ophthalmology (Auckland, N.Z.) · 2026Article
- Management and outcomes of cataract surgery in uveitic eyes with chronic hypotony: a two-case series.Journal of ophthalmic inflammation and infection · 2025Article
- Review
- Unanswered questions regarding the pathogenesis of late onset posterior capsular opacification.Frontiers in ophthalmology · 2025Review
- Innovative Polymeric Biomaterials for Intraocular Lenses in Cataract Surgery.Journal of functional biomaterials · 2024Review
- Use of Intracameral Tissue Plasminogen Activator During Uveitic Cataract Surgery.Ocular immunology and inflammation · 2024Article
- Complete Blood Cell Count-Derived Inflammation Biomarkers and the Need for Laser Capsulotomy Due to Posterior Capsule Opacification Following Cataract Surgery.Journal of inflammation research · 2024Article
- Prognostic factors of cataract surgery in patients with uveitis.International ophthalmology · 2023Article
- Early and Late Complications after Cataract Surgery in Patients with Uveitis.Medicina (Kaunas, Lithuania) · 2023Article
- Long-term outcomes of small-incision cataract surgery in patients with uveitis.Indian journal of ophthalmology · 2022Article
- Corneal Endothelial Transplantation in Uveitis: Incidence and Risk Factors.American journal of ophthalmology · 2022Article
- Dynamic changes of Elschnig pearls posterior capsule opacification.BMJ case reports · 2022Article
- Uveitis-mediated immune cell invasion through the extracellular matrix of the lens capsule.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2022Article
- Immune responses to injury and their links to eye disease.Translational research : the journal of laboratory and clinical medicine · 2021Review
- Timing of Quiescence and Uveitis Recurrences After Cataract Surgery in Patients with a History of Uveitis.Ophthalmology and therapy · 2021Article
- Immune cells in lens injury repair and fibrosis.Experimental eye research · 2021Review
- Utilizing dexamethasone intravitreal implant to control postoperative inflammation in refractory uveitis undergoing cataract surgery.International journal of ophthalmology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo assess the long-term outcomes of phacoemulsification and intraocular lens (IOL) implantation in eyes with uveitis.
methodsOne hundred and five eyes of 81 patients, who underwent phacoemulsification and IOL implantation between January 2009 and July 2016, were included in this study. The demographic data, preoperative clinical findings, postoperative outcomes, and intraoperative and postoperative complications were recorded. All collected data and risk factors with regard to visual prognosis were analyzed with the help of the Statistical Package for the Social Sciences version 20.0 software program (IBM Corp., Armonk, NY, USA).
resultsDuring follow-up (mean: 35.2 ± 22.2 months), corrected distance visual acuity (CDVA) improved in 87.7% of all eyes and reached a level of 0.3 LogMAR or greater in 61.3% of eyes. Postoperative complications included posterior capsule opacification (50.9%), posterior synechiae (21.7%), cystoid macular edema (16%), epiretinal membrane (13.2%), glaucoma (11.3%), increased intraocular pressure (8.5%), and severe inflammation (6.6%). Uveitis recurred in 55.7% of all eyes. The risk for the development of cystoid macular edema was found to be associated with recurrence in the early postoperative period. Low visual acuity risk was 11.1-fold higher with macular scarring (p = 0.001) and 14-fold higher with optic atrophy (p < 0.001), respectively.
conclusionsWith appropriate management during the pre- and postoperative periods, phacoemulsification and IOL implantation surgery can be safe and effective in eyes with uveitis. However, great caution must be taken to prevent complications both before and after the surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.